2022-04057. Bulk Manufacturer of Controlled Substances Application: Synthcon LLC  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Synthcon LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on December 2, 2021, Start Printed Page 10821 Synthcon LLC, 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915-3538, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    3-FMC1233I
    Cathinone1235I
    Methcathinone1237I
    4-FMC1238I
    Pentedrone1246I
    Mephedrone(4-Methyl-N-methylcathinone)1248I
    4-MEC1249I
    Naphyrone1258I
    N-Ethylamphetamine1475I
    N,N-Dimethylamphetamine1480I
    Aminorex1585I
    Cis-4-Methylaminorex1590I
    GHB2010I
    Methaqualone2565I
    Mecloqualone2572I
    JWH-2506250I
    ADB-PINACA7035I
    JWH-0187118I
    JWH-0737173I
    JWH-2007200I
    JWH-2037203I
    4-Methyl-alpha-ethylaminopentiophenone7245I
    N-Ethyhexedrone7246I
    AET7249I
    Ibogaine7260I
    CP-47,4977297I
    CP-47,497 C8 HOMOLOG7298I
    LSD7315I
    2C-T-77348I
    Tetrahydrocannabinols7370I
    Mescaline7381I
    2C-T-27385I
    3,4,5-TMA7390I
    DOB7391I
    2CB7392I
    DOM7395I
    2,5-DMA7396I
    JWH-3987398I
    DOE7399I
    MDA7400I
    5-METHOXY-MDA7401I
    N-HYDROXY-MDA7402I
    MDEA7404I
    MDMA7405I
    PMA7411I
    5-MeO-DMT7431I
    AMT7432I
    Bufotenine7433I
    DET7434I
    DMT7435I
    Psilocybin7437I
    Psilocin7438I
    5-Methoxy-N,N-diisopropyltryptamine7439I
    4-Methyl-alpha-pyrrolidinohexiophenone7446I
    PCE7455I
    PCPy7458I
    TCP7470I
    TCPy7473I
    JB3237482I
    JB3367484I
    BZP7493I
    4-MePPP7498I
    2C-D7508I
    2C-E7509I
    2C-H7517I
    2C-I7518I
    2C-C7519I
    2C-N7521I
    2C-P7524I
    2C-T-47532I
    Start Printed Page 10822
    MDPV7535I
    25B-NBOME7536I
    25C-NBOME7537I
    25I-NBOME7538I
    Methylone7540I
    Butylone7541I
    Pentylone7542I
    N-Ethylpentyloe7543I
    Alpha-Pyrrolidinohexanophenone7544I
    Alpha-PVP7545I
    Alpha-PBP7546I
    Ethylone7547I
    AM-6947694I
    Etorphine9056I
    Heroin9200I
    Normorphine9313I
    Acetorphine9319I
    U-477009547I
    AH-79219551I
    MT-459560I
    Acetylmethadol9601I
    Allylprodine9602I
    Alphacetylmethadol9603I
    Alphameprodine9604I
    Alphamethadol9605I
    Benzethidine9606I
    Betacetylmethadol9607I
    Clonitazine9612I
    Isontonitazene9614I
    Diampromide9615I
    Diethylthiambutene9616I
    Dimethylthiambutene9619I
    Etonitazene9624I
    Ketobemidone9628I
    MPPP9661I
    PEPAP9663I
    Tilidine9750I
    Acryl Fentanyl9811I
    Para-fluorofentanyl9812I
    3-Methylfentanyl9813I
    Alpha-methylfentanyl9814I
    Acetyl-alpha-methylfentanyl9815I
    Ortho-fluorofentanyl9816I
    Acetylfentanyl9821I
    Butyrylfentanyl9822I
    Para-fluorofentanyl9823I
    4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide)9824I
    Methoxyacetyl fentanyl9825I
    Para-chloroisobutyryl fentanyl9826I
    Isobutyrylfentanyl9827I
    Beta-Hydroxyfentanyl9830I
    Beta-Hydroxy-3-methylfentanyl9831I
    Alpha-Methylthiofentanyl9832I
    3-Methylthiofentanyl9833I
    Furanylfentanyl9834I
    Thiofentanyl9835I
    Beta-Hydroxythiofentanyl9836I
    Para-Methoxybutyryl Fetnanyl9837I
    Ocfentanil9838I
    Valeryl Fentanyl9840I
    Tetrahydrofuranyl Fentanyl9843I
    Crotonyl Fentanyl9844I
    Cyclopropyl Fentanyl9845I
    Cyclopentyl Fentanyl9847I
    Fentanyl Related Compounds9850I
    Amphetamine1100II
    Methamphetamine1105II
    1-Phenylcyclohexylamine7460II
    PCP7471II
    ANPP8333II
    Norfentanyl8366II
    P2P8501II
    PCC8603II
    Alphaprodine9010II
    Start Printed Page 10823
    Anileridine9020II
    Cocaine9041II
    Diphenoxylate9170II
    Ecgonine9180II
    Levorphanol9220II
    Meperidine9230II
    Meperidine Intermediate-A9232II
    Meperidine Intermediate-B9233II
    Meperidine Intermediate-C9234II
    Dextropropoxyphene9273II
    Morphine9300II
    Levo-alphacetylmethadol9648II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Carfentanil9743II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture the listed controlled substances as analytical materials, proficiency test materials, and academic research materials for distribution to its customers. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Matthew J. Strait,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2022-04057 Filed 2-24-22; 8:45 am]

    BILLING CODE P

Document Information

Published:
02/25/2022
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2022-04057
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2022. Such persons may also file a written request for a hearing on the application on or before April 26, 2022.
Pages:
10820-10823 (4 pages)
Docket Numbers:
Docket No. DEA-964
PDF File:
2022-04057.pdf